Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nab-Paclitaxel vs Paclitaxel with Concurrent Radiation in Inoperable Stage IIIA/B NSCLC
NCT01757288Phase 2Completed
- Sponsor
- UT Southwestern Medical Center
- Start
- Mar 2013
- Primary completion
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of paclitaxel in non-small cell lung cancer (NSCLC), sponsored by UT Southwestern Medical Center. Started Mar 2013; status: completed.
02
Drugs
paclitaxel
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT01757288.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01757288.